Hydrolysable hydrogels for controlled release
View Patent ↗The present invention relates to a biodegradable hydrogel comprising bonds which are hydrolyzable under physiological conditions. More particularly, the hydrogel consists of two interpenetrating polymer networks interconnected to one another through hydrolyzable spacers. In addition, the invention relates to a method for the preparation of a hydrogel, wherein macromolecules, e.g., polymers which contain bonds which are hydrolyzable under physiological conditions, are cross-linked in an aqueous solution.
1. A biodegradable hydrogel comprising a network of polymer chains, wherein said network contains polymer backbones which are interconnected to one another through spacers formed by crosslinked units, wherein the spacers contain, between said polymer backbone and the crosslinked unit, one or more bonds which are hydrolysable under physiological conditions,
wherein at least one of the bonds which are hydrolysable under physiological conditions comprises a carbonate ester bond;
wherein said crosslinked unit is comprised of a polymer of a) (poly)glycolic acid and/or (poly)lactic acid, and b) at least one monomer containing an acrylate, methacrylate and/or hydroxyalkyl methacrylate groups, wherein at least one of the groups is connected to the polymer backbone; and
wherein said polymer backbones are selected from the group consisting of dextran, derivitized dextran, starch, starch derivatives, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinylpyrrolidone, polyvinylalcohol, polyacrylate, polymethacrylate, and polyethylene glycol.
2. The hydrogel of claim 1 , wherein said carbonate ester bond is formed from coupling crosslinkable units to said polymer backbone using carbonyl di-imidazole as a coupling agent.
3. The hydrogel of claim 1 , wherein said polymer backbones in non-crosslinked form are water-soluble.
4. The hydrogel of claim 2 , wherein said polymer backbones in non-crosslinked form are water-soluble.
5. The hydrogel of claim 3 , wherein said water-soluble polymer is dextran or a derivatised dextran.
6. The hydrogel of claim 4 , wherein said water-soluble polymer is dextran or a derivatised dextran.
7. The hydrogel of claim 1 , further comprising a drug.
8. The hydrogel of claim 7 , wherein the drug is a proteinaceous material.
9. A crosslinkable polymer composition capable of forming a hydrogel, comprising
a) a hydrophilic polymeric backbones, and
b) at least one spacer, the spacer comprising one or more bonds which are hydrolysable under physiological conditions and at least one crosslinkable group,
wherein at least one of the bonds which are hydrolysable under physiological conditions comprises a carbonate ester bond;
wherein said crosslinkable group is comprised of a polymer of i) (poly)glycolic acid and/or (poly)lactic acid, and ii) at least one monomer containing acrylate, methacrylate and/or hydroxyalkyl methacrylate groups; and
wherein said polymer backbone is selected from the group consisting of dextran, derivitized dextran, starch, starch derivatives, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinylpyrrolidone, polyvinylalcohol, polyacrylate, polymethacrylate, and polyethylene glycol.
10. The crosslinkable polymer composition of claim 9 , wherein said spacer is reacted with a carbonyl-di-imidazole to form said carbonate ester bond between the polymer backbone and the crosslinkable unit.
11. The crosslinkable polymer composition of claim 9 , wherein said polymeric backbone is derived from dextran or derivatised dextran.
12. A crosslinked polymer capable of forming a hydrogel, obtained by coupling the spacer to the polymeric backbone of claim 9 and crosslinking the resulting coupled polymer composition.
13. A crosslinked polymer capable of forming a hydrogel, obtained by coupling the spacer to the polymeric backbone of claim 10 and crosslinking the resulting coupled polymer composition.
14. A crosslinked polymer capable of forming a hydrogel, obtained by coupling the spacer to the polymeric backbone of claim 11 and crosslinking the resulting coupled polymer composition.
15. A method for preparing a hydrogel, which method comprises coupling the spacer to the polymeric backbone as defined in claim 9 , and crosslinking the resulting coupled polymer composition in an aqueous medium.
16. A method for preparing a hydrogel, which method comprises coupling each of two spacers to each of two polymeric backbones as defined in claim 9 , and
crosslinking the at least two resulting polymers in an aqueous medium.
17. A method for preparing a hydrogel, which method comprises coupling each of two spacers to each of two polymeric backbones as defined in claim 10 , and
crosslinking the at least two resulting polymers in an aqueous medium.
18. A method for preparing a hydrogel, which method comprises coupling each of two spacers to each of two polymeric backbones as defined in claim 11 , and
crosslinking the at least two resulting polymers in an aqueous medium.
19. The method of claim 15 , wherein a drug is present during the crosslinking step.
20. The method of claim 19 , wherein the drug is a proteinaceous material.
21. The method of claim 16 , wherein a drug is present during the crosslinking step.
22. The method of claim 21 , wherein the drug is a proteinaceous material.
23. The hydrogel of claim 9 , wherein the acrylate, methacrylate, and/or hydroxyalkyl methacrylate groups that are positioned in a pendant or terminal position relative to the (poly)glycolic and/or (poly)lactic acid.
24. The hydrogel of claim 9 , wherein the acrylate, methacrylate, and/or hydroxyalkyl methacrylate groups that are positioned in the terminal position relative to the (poly)glycolic and/or (poly)lactic acid.